Dante J. Pieramici

10.4k total citations · 5 hit papers
103 papers, 6.8k citations indexed

About

Dante J. Pieramici is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, Dante J. Pieramici has authored 103 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Ophthalmology, 56 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Neurology. Recurrent topics in Dante J. Pieramici's work include Retinal Diseases and Treatments (64 papers), Retinal Imaging and Analysis (30 papers) and Retinal and Optic Conditions (28 papers). Dante J. Pieramici is often cited by papers focused on Retinal Diseases and Treatments (64 papers), Retinal Imaging and Analysis (30 papers) and Retinal and Optic Conditions (28 papers). Dante J. Pieramici collaborates with scholars based in United States, United Kingdom and Switzerland. Dante J. Pieramici's co-authors include Robert L. Avery, Melvin Rabena, Alessandro Castellarin, Ma'an Nasir, Matthew Giust, Eugene de Juan, Mark S. Humayun, Gildo Y Fujii, Tom Chang and Maurício Maia and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Ophthalmology.

In The Last Decade

Dante J. Pieramici

99 papers receiving 6.5k citations

Hit Papers

Intravitreal Bevacizumab ... 2006 2026 2012 2019 2006 2006 2006 2014 2024 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
    2006 953 citations Robert L. Avery, Dante J. Pieramici et al. Ophthalmology profile →
  2. Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
    2006 603 citations Robert L. Avery, Dante J. Pieramici et al. Ophthalmology profile →
  3. Relationship between Optical Coherence Tomography–Measured Central Retinal Thickness and Visual Acuity in Diabetic Macular Edema
    2006 469 citations Neil M. Bressler, Dante J. Pieramici et al. Ophthalmology profile →
  4. Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
    2014 284 citations Robert L. Avery, Alessandro Castellarin et al. profile →
  5. Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
    2024 46 citations Robert L. Avery, Jeffrey S. Heier et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dante J. Pieramici United States 35 6.2k 4.7k 959 601 347 103 6.8k
Carl D. Regillo United States 45 6.9k 1.1× 5.5k 1.2× 1.7k 1.7× 585 1.0× 225 0.6× 226 8.3k
Khalil Ghasemi Falavarjani Iran 31 3.2k 0.5× 2.4k 0.5× 463 0.5× 354 0.6× 203 0.6× 177 3.9k
Antonio Capone United States 37 3.4k 0.5× 4.0k 0.9× 880 0.9× 455 0.8× 169 0.5× 191 5.6k
Andrew A. Moshfeghi United States 30 2.9k 0.5× 1.9k 0.4× 567 0.6× 174 0.3× 189 0.5× 111 3.5k
Nicolas Feltgen Germany 33 4.0k 0.6× 2.4k 0.5× 435 0.5× 595 1.0× 235 0.7× 195 4.7k
John A. Sorenson United States 42 8.4k 1.4× 5.3k 1.1× 771 0.8× 480 0.8× 301 0.9× 92 9.2k
Jason S. Slakter United States 48 8.1k 1.3× 5.3k 1.1× 1.1k 1.1× 436 0.7× 294 0.8× 133 9.0k
Sharon Fekrat United States 30 2.8k 0.5× 2.0k 0.4× 301 0.3× 441 0.7× 105 0.3× 191 3.3k
Dov Weinberger Israel 33 1.8k 0.3× 1.7k 0.4× 414 0.4× 187 0.3× 178 0.5× 162 3.1k
David Sarraf United States 45 6.3k 1.0× 4.3k 0.9× 815 0.8× 733 1.2× 131 0.4× 259 7.0k

Countries citing papers authored by Dante J. Pieramici

Since Specialization
Citations

This map shows the geographic impact of Dante J. Pieramici's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dante J. Pieramici with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dante J. Pieramici more than expected).

Fields of papers citing papers by Dante J. Pieramici

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dante J. Pieramici. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dante J. Pieramici. The network helps show where Dante J. Pieramici may publish in the future.

Co-authorship network of co-authors of Dante J. Pieramici

This figure shows the co-authorship network connecting the top 25 collaborators of Dante J. Pieramici. A scholar is included among the top collaborators of Dante J. Pieramici based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dante J. Pieramici. Dante J. Pieramici is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eichenbaum, David, Arshad M. Khanani, Dante J. Pieramici, et al.. (2025). Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration. American Journal of Ophthalmology. 275. 14–26.
2.
Khanani, Arshad M., David S. Boyer, Charles C. Wykoff, et al.. (2023). Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study. EClinicalMedicine. 67. 102394–102394. 35 indexed citations
3.
Pieramici, Dante J., Arshad M. Khanani, Flávia Brunstein, et al.. (2020). Phase 1 safety study of intravitreal (ITV) Anti-High Temperature Requirement A1 (aHtrA1), a novel serine protease inhibitor, in patients with Geographic Atrophy (GA). Investigative Ophthalmology & Visual Science. 61(7). 1942–1942. 1 indexed citations
4.
Giust, Jack, Alessandro Castellarin, Nathan Steinle, et al.. (2018). Treat and Extend Versus Bi-monthly dosing with Aflibercept for the Treatment of Diabetic Macular Edema, One Year Outcomes (EVADE Study). Investigative Ophthalmology & Visual Science. 59(9). 1957–1957. 1 indexed citations
5.
Pieramici, Dante J., Frank G. Holz, Jeffrey S. Heier, et al.. (2018). Lampalizumab for geographic atrophy (GA) in age-related macular degeneration (AMD): pooled results of the Chroma and Spectri phase 3 randomized clinical trials (RCTs). Investigative Ophthalmology & Visual Science. 59(9). 4948–4948. 2 indexed citations
6.
Steinle, Nathan, Dilsher S. Dhoot, Dante J. Pieramici, et al.. (2016). Comparison of Three Non-surgical Treatments for Vitreomacular Traction (VMT). Investigative Ophthalmology & Visual Science. 57(12). 1 indexed citations
7.
Steinle, Nathan, Dilsher S. Dhoot, Carlos Quezada-Ruiz, et al.. (2015). Intravitreal Perfluoropropane Gas (C3F8) Versus Ocriplasmin for Vitreomacular Traction (VMT). Investigative Ophthalmology & Visual Science. 56(7). 3515–3515. 1 indexed citations
8.
Quezada-Ruiz, Carlos, et al.. (2014). Optimal Incubation Period following Topical Anesthesia prior to Intravitreal Injections. Investigative Ophthalmology & Visual Science. 55(13). 583–583. 1 indexed citations
9.
Avery, Robert L., Alessandro Castellarin, Nathan Steinle, et al.. (2014). Systemic Pharmacokinetics Following Intravitreal Injections of Ranibizumab, Bevacizumab or Aflibercept in Patients with DME. Investigative Ophthalmology & Visual Science. 55(13). 586–586. 2 indexed citations
10.
Steinle, Nathan, Carlos Quezada-Ruiz, Dante J. Pieramici, et al.. (2014). Outer Band Reflectivity Changes on SD-OCT Following Intravitreal Ocriplasmin for Vitreomacular Traction (VMT) and macular holes (MH). Investigative Ophthalmology & Visual Science. 55(13). 296–296. 3 indexed citations
11.
Zhao, Ling, Seanna Grob, Robert L. Avery, et al.. (2013). Common Variant in VEGFA and Response to Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration. Current Molecular Medicine. 13(6). 929–934. 28 indexed citations
12.
Pieramici, Dante J., et al.. (2012). The Phase III MIVI-TRUST Clinical Trial Data: Subgroup Responder Analysis of a Single Intravitreal Injection of Ocriplasmin in patients with Full Thickness Macular Hole. Investigative Ophthalmology & Visual Science. 53(14). 947–947. 2 indexed citations
13.
Pieramici, Dante J., Sarah Risard, & Melvin Rabena. (2009). RETINAL NEOVASCULARIZATION ASSOCIATED WITH A RETINAL ARTERIAL MACROANEURYSM. Retinal Cases & Brief Reports. 3(4). 415–418. 2 indexed citations
14.
Scott, Ingrid U., Allison R. Edwards, Neil M. Bressler, et al.. (2007). A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema. Ophthalmology. 114(10). 1860–1867.e7. 344 indexed citations
15.
Pieramici, Dante J., Robert L. Avery, Alessandro Castellarin, et al.. (2007). Ranibizumab for the Treatment of Macular Edema Associated With Perfused Central Retinal Vein Occlusions. Investigative Ophthalmology & Visual Science. 48(13). 313–313.
16.
Avery, Robert L., Dante J. Pieramici, Melvin Rabena, et al.. (2007). Intravitreal Bevacizumab (Avastin®) in the Surgical Treatment of Proliferative Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 48(13). 4031–4031. 1 indexed citations
17.
18.
Polito, Antonio, Kah‐Guan Au Eong, Michael X. Repka, & Dante J. Pieramici. (2001). Bilateral Retinal Hemorrhages in a Preterm Infant With Retinopathy of Prematurity Immediately Following Cardiopulmonary Resuscitation. Archives of Ophthalmology. 119(6). 913–913. 8 indexed citations
19.
Pieramici, Dante J., et al.. (1996). Open-globe Injury. Ophthalmology. 103(11). 1798–1803. 144 indexed citations
20.
Pieramici, Dante J. & Leonard M. Parver. (1995). A mechanistic approach to ocular trauma. Ophthalmology Clinics of North America. 8(4). 569–587. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl D. Regillo Breakdown of academic impact, for papers by Khalil Ghasemi Falavarjani Breakdown of academic impact, for papers by Antonio Capone Breakdown of academic impact, for papers by Andrew A. Moshfeghi Breakdown of academic impact, for papers by Nicolas Feltgen Breakdown of academic impact, for papers by John A. Sorenson Breakdown of academic impact, for papers by Jason S. Slakter Breakdown of academic impact, for papers by Sharon Fekrat Breakdown of academic impact, for papers by Dov Weinberger Breakdown of academic impact, for papers by David Sarraf
Rankless by CCL
2026